US pharmaceutical firm Eli Lilly is to invest €330 million in a new facility at its Kinsale campus in Cork. The investment will lead to the creation of 200 new jobs at the facility, as well as a further 300 construction jobs which will be created as part of the building works. This will bring Eli Lilly’s total employment in Ireland up to almost 1,000. The new facility will expand the Kinsale site's existing biopharmaceutical mission with the establishment of an additional world-class commercialisation and manufacturing facility, which will further enhance the company’s ability to bring treatments for illnesses such as cancer and diabetes to patients worldwide.
